http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27705054

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Review
endingPage 3262
issn 1476-5381
0007-1188
issueIdentifier 16
pageRange 3251-3262
publicationName British Journal of Pharmacology
startingPage 3251
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation Li T, Yang Z, Jiang S, Di W, Ma Z, Hu W, Chen F, Reiter RJ, Yang Y. Melatonin: does it have utility in the treatment of haematological neoplasms? British J Pharmacology. 2017 Sep 09;175(16):3251–62. doi: 10.1111/bph.13966.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_238467ffb1f26b4db0ffbd60b23f84a0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8281-4459
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b3918bd59755b15a37c13f0cad29c22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1163-2359
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf1e3a6c0197af9e7568d2b94a7e2749
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b5ad83ec4b1db59fc227c23d0e98441
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c487a7aa7e21a1d5ecb7f1ccee812c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5555-2764
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8ad720b2f9ef91a30baf97461ee3d569
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a82006ce68fe82135c820ffe011e3b1b
date 2017-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1111/bph.13966
https://pubmed.ncbi.nlm.nih.gov/PMC6057911
https://pubmed.ncbi.nlm.nih.gov/28880375
isPartOf https://portal.issn.org/resource/ISSN/0007-1188
https://portal.issn.org/resource/ISSN/1476-5381
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Melatonin: does it have utility in the treatment of haematological neoplasms?
discusses http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0013319
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D008550Q000627
http://id.nlm.nih.gov/mesh/D019337Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D019337Q000378
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008550Q000378
http://id.nlm.nih.gov/mesh/D000970Q000009
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122074
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID896
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10364
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Total number of triples: 48.